| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/17/2008 | US20080171724 Phosphonate Derivatives of Mycophenolic Acid |
| 07/17/2008 | US20080171723 Boronic Acid Aryl Analogs |
| 07/17/2008 | US20080171718 The atisense agent, an oblimersen compound, is administered twice weekly, the tyrosine kinase inhibitor is administered five times weekly, and the chemo agent once weekly; synergistic |
| 07/17/2008 | US20080171711 One mRNA contains a domain coding for a tumor antigen and one mRNA contains a domain coding for an immunogenic protein; genetic vaccines; gene therapy; improved stability |
| 07/17/2008 | US20080171710 Reducing oxidation in activated neural progenitor cells, islets of Langerhan or oligodendrocytes by contacting with an interupting agent; screening for pro-oxidation toxicants; cancer treatments; testing oxidation levels in patients at risk for autism, Alzheimer's Disease and environmental toxin exposure |
| 07/17/2008 | US20080171709 Pharmaceutical Composition Comprising An Antiviral Agent, An Antitumoral Agent Or An Antiparasitic Agent, And An Active Agent Selected Among Carveol, Thymol, Eugenol, Borneol,And Carvacrol |
| 07/17/2008 | US20080171703 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 07/17/2008 | US20080171697 Mitochondriotoxic cyclic polypeptides that induce endocytolysis or angiogenesis in human endothelial cells expressing alpha V beta 3 receptors; anticarcinogenic agents for adenomas, melanomas, osteosarcomas, prostate, breast, colon, or pancreatic cancers; antiarthritici agents; diabetic retinopathy |
| 07/17/2008 | US20080171693 Such as Survivn; antiproliferative, antitumor agents; apoptosis; a polypeptide peptidomimetic that includes the amino acid sequence His-Ser-Ser-Gly-Cys |
| 07/17/2008 | US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors; |
| 07/17/2008 | US20080171390 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/17/2008 | US20080171090 Dispersing core fine particles and coating layer comprising lipids or surfactants in liquid containing a polar solvent in which coating layer is soluble such that core fine particles are not dissolved; drug delivery of genes, DNA, RNA, oligonucleotides, plasmids, and/or siRNA; foods; antitumor agents |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity |
| 07/17/2008 | US20080171057 Using proteomic profiles as diagnostic indicators of metabolic disorders; bioinformatics |
| 07/17/2008 | US20080171056 Enhancing therapeutic efficacy of antitumor agents via concurrent expose to receptor specific immunoglobulins; tissue targeted therapy |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171045 Compositions and Methods for Diagnosing and Treating Cancer |
| 07/17/2008 | US20080171040 Antibody-drug conjugates and methods |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171033 Dipeptidyl peptidase-4 (DPP-4) (CD26) for use in treating diabetic retinopathy, psoriasis and arthritis; cytokine inhibition of interleukin-1 activity |
| 07/17/2008 | US20080171027 Compositions and Methods for Elimination of Unwanted Cells |
| 07/17/2008 | US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy |
| 07/17/2008 | US20080171023 Nutrient broth comprising nervous system tissue is exposed to tumor associated antigen in order to ellicit enhanced CD8+T cell response; administered to cancer patient to treat cell proliferative disorders; immunotherapy |
| 07/17/2008 | US20080171022 Using patients cryopreserved bone marrow stem cells to replace/transplant in to regions treated with tumor ablation therapies |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | US20080171016 Death Domain Containing Receptors |
| 07/17/2008 | US20080170997 Compositions for the treatment and prevention of cancer |
| 07/17/2008 | US20080170993 Thymidine analogs for imaging |
| 07/17/2008 | US20080170988 Method of Preparing Nanoparticles of Alginate-Galactosyl-Polylsine |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE202008005023U1 Verwendung von α-Liponsäure und Coenzym Q10 zur selektiven Reduktion des visceralen Fettgewebes Use of α-lipoic acid and coenzyme Q10 for the selective reduction of visceral adipose tissue |
| 07/17/2008 | DE112006002340T5 Arzneimittel, verwendbar zur Behandlung von Prostatakrebs A pharmaceutical composition useful for the treatment of prostate cancer |
| 07/17/2008 | DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds |
| 07/17/2008 | CA2675334A1 Reducing side effects associated with ala-based photodynamic therapy |
| 07/17/2008 | CA2675291A1 Killer ig-like receptor (kir) antibodies, formulations, and uses thereof |
| 07/17/2008 | CA2675231A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2674604A1 Formulations of deacetylase inhibitors |
| 07/17/2008 | CA2674318A1 Cyclized derivatives as eg-5 inhibitors |
| 07/17/2008 | CA2674315A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 07/17/2008 | CA2673972A1 Dbait and its standalone uses thereof |
| 07/17/2008 | CA2673869A1 Method of treating multidrug resistant cancers |
| 07/17/2008 | CA2673683A1 Compounds and method for treatment of cancer |
| 07/17/2008 | CA2673652A1 Bis-aryl amide derivatives and methods of use |
| 07/17/2008 | CA2670270A1 Use of iap inhibitors for the treatment of acute myeloid leukemia |
| 07/16/2008 | EP1944607A2 Toluidine blue O compounds and their manufacture, analysis and use |
| 07/16/2008 | EP1944369A1 Dbait and its standalone uses thereof |
| 07/16/2008 | EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/16/2008 | EP1944307A2 Synthetic Salicylihalamides, Apicularens and Derivatives Thereof |
| 07/16/2008 | EP1944297A1 Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof |
| 07/16/2008 | EP1944039A1 Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor |
| 07/16/2008 | EP1944035A1 Method for reducing pain using oncolytic viruses |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1944026A2 Use of EDG receptor binding agents in cancer |
| 07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 07/16/2008 | EP1943257A2 Fibroblast activation protein inhibitor compounds and methods |
| 07/16/2008 | EP1943253A1 Novel crystalline forms |
| 07/16/2008 | EP1943244A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors |
| 07/16/2008 | EP1943233A2 Compounds and compositions for protein kinase inhbitors |
| 07/16/2008 | EP1943232A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 07/16/2008 | EP1942950A2 Biodegradable composite for internal local radiotherapy |
| 07/16/2008 | EP1942944A2 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 07/16/2008 | EP1942927A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 07/16/2008 | EP1942918A1 Black tea polyphenols and uses thereof |
| 07/16/2008 | EP1942900A2 Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases |
| 07/16/2008 | EP1942884A2 Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
| 07/16/2008 | EP1763356B1 Composition comprising a survivin antisense oligonucleotide and gemcitabine for the treatment of cancer |
| 07/16/2008 | EP1485160B1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1337270B1 Long-acting interferon and interlukin derivatives and pharmaceutical compositions comprising them |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1286966B1 4-aminopiperidine derivatives and their use as medicine |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1200108B1 Use of ginkgo extract for treating cancer which is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 07/16/2008 | EP1180123B1 Immunoconjugates having high binding affinity |
| 07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 07/16/2008 | EP1124550B1 Uses and compositions for selective cancer chemotherapy |
| 07/16/2008 | EP1082134B1 Use of haptenised tumour cells and extracts thereof |
| 07/16/2008 | EP1073654B1 2,3-olefinic epothilone derivatives |
| 07/16/2008 | EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/16/2008 | EP0983072B2 Use of inulin for the manufacture of a medicament for the prevention and treatment of colon cancer |
| 07/16/2008 | CN101223169A Pyrrole(2,3-b)pyridine derivatives protein kinase inhibitors |
| 07/16/2008 | CN101223168A Heterocyclic JANUS kinase 3 inhibitors |
| 07/16/2008 | CN101223165A Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 07/16/2008 | CN101223150A Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 07/16/2008 | CN101223139A 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 07/16/2008 | CN101222941A A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF alpha and a carrier protein |
| 07/16/2008 | CN101222938A Use of inhibitors of histone deacetylases in combination with NASAID for the therapy of cancer and/or inflammatory diseases |
| 07/16/2008 | CN101222926A Methods and compositions for treating or preventing cancer |
| 07/16/2008 | CN101222925A Combination of a pyrimidylaminobenzamide and an mTOR kinase inhibitor |
| 07/16/2008 | CN101222917A Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer |
| 07/16/2008 | CN101222916A Phenol derivatives and their use to modulate PKB activity |
| 07/16/2008 | CN101220101A Trichoderma pseudokoningii exocellular polysaccharide, preparation method and application thereof |
| 07/16/2008 | CN101220100A Separation and purification method for squash polyoses and use of obtained component |
| 07/16/2008 | CN101220083A Synthetic polypeptide and uses thereof |
| 07/16/2008 | CN101220068A A set of geldanamycin derivant and method for preparing the same |
| 07/16/2008 | CN101220059A Ru(II) complex with anticancer liveness and method for preparing the same |